Keep Punching Guys........................5 Dec 2019 03:47
Certainly was a boost to be able to watch Cliff Holloway speaking at the Investival Conference on the 19th November. Short of getting updates and new news by way of RNS and having just watched it for the second time, it felt for me like getting reacquainted with the share again.
I felt Cliff Holloway spoke particularly well, possibly his best presentation yet, and next year sounds particularly exciting with what is planned. Whilst the focus for newsflow will be Immunobody and Moditope, I felt he had a particular passion in the TCR collaboration with BioNTech, and the Glycans, Mabs Good to hear to Martin Diggle was there to discuss why they invested in Scancell, for obvious reasons, and I just wonder how much of a role the video played in us seeing a 200k Buy yesterday, along with another 255k. Even the ask moved up 9first time for days) 4.90,4.93 and 4.98, ending the day with a volume of475k of which 468k were buys (another few weeks of that, will help, lol)
So my impression was all platforms are well in hand, converging into clinical trials around the same time and with open label trials data will be available as we go. Avidamab sounds exciting, as does all the data collected with the Glycan, Mabs.
Happy to wait to hear further, confident in our ability to progress further and there should be a few good twists along the way. To a good day again, first targt lets get back in the 5"s ASAP, tomorrow will do, lol.